250 related articles for article (PubMed ID: 29486339)
21. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication.
Chung KF; Yu YM; Yeung WF
J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911
[TBL] [Abstract][Full Text] [Related]
22. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
23. A case series on the use of lavendula oil capsules in patients suffering from major depressive disorder and symptoms of psychomotor agitation, insomnia and anxiety.
Fißler M; Quante A
Complement Ther Med; 2014 Feb; 22(1):63-9. PubMed ID: 24559818
[TBL] [Abstract][Full Text] [Related]
24. Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
Hashimoto K; Bruno D; Nierenberg J; Marmar CR; Zetterberg H; Blennow K; Pomara N
Transl Psychiatry; 2016 Mar; 6(3):e744. PubMed ID: 26926880
[TBL] [Abstract][Full Text] [Related]
25. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
26. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder.
Hung YY; Huang KW; Kang HY; Huang GY; Huang TL
Psychopharmacology (Berl); 2016 May; 233(9):1707-14. PubMed ID: 26415953
[TBL] [Abstract][Full Text] [Related]
29. Right temporal activation differs between melancholia and nonmelancholic depression: a multichannel near-infrared spectroscopy study.
Tsujii N; Mikawa W; Akashi H; Tsujimoto E; Adachi T; Kirime E; Takaya M; Yanagi M; Shirakawa O
J Psychiatr Res; 2014 Aug; 55():1-7. PubMed ID: 24780385
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
Inamdar A; Merlo-Pich E; Gee M; Makumi C; Mistry P; Robertson J; Steinberg E; Zamuner S; Learned S; Alexander R; Ratti E
J Psychopharmacol; 2014 Jun; 28(6):570-81. PubMed ID: 24699061
[TBL] [Abstract][Full Text] [Related]
31. Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study.
Hashimoto K; Ishima T; Sato Y; Bruno D; Nierenberg J; Marmar CR; Zetterberg H; Blennow K; Pomara N
Sci Rep; 2017 Jun; 7(1):3485. PubMed ID: 28615661
[TBL] [Abstract][Full Text] [Related]
32. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
J Affect Disord; 2009 Feb; 113(1-2):179-82. PubMed ID: 18533274
[TBL] [Abstract][Full Text] [Related]
33. Relationship between the prefrontal function and the severity of the emotional symptoms during a verbal fluency task in patients with major depressive disorder: a multi-channel NIRS study.
Liu X; Sun G; Zhang X; Xu B; Shen C; Shi L; Ma X; Ren X; Feng K; Liu P
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():114-21. PubMed ID: 24842802
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.
Mizui T; Hattori K; Ishiwata S; Hidese S; Yoshida S; Kunugi H; Kojima M
J Psychiatr Res; 2019 Jun; 113():190-198. PubMed ID: 30986693
[TBL] [Abstract][Full Text] [Related]
35. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
36. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
37. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.
Wan Y; Liu Y; Wang X; Wu J; Liu K; Zhou J; Liu L; Zhang C
PLoS One; 2015; 10(3):e0121975. PubMed ID: 25763923
[TBL] [Abstract][Full Text] [Related]
38. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
[TBL] [Abstract][Full Text] [Related]
39. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls.
Schmidt FM; Brügel M; Kratzsch J; Strauss M; Sander C; Baum P; Thiery J; Hegerl U; Schönknecht P
Neurosci Lett; 2010 Oct; 483(1):20-2. PubMed ID: 20655364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
